343.60001 EUR
2
0.58%
Last update Nov 18, 4:21 PM CET
Main market
Day range
343.60001
343.60001
Previous close
345.60001
Open
343.60001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
343.60
2
0.58%

Financials

Balance sheet

Fundamentals currency is USD
Fiscal date 2024
Total assets 3.6B
Current assets 2.8B
Cash
Cash equivalents
Cash and cash equivalents 823.6M
Other short term investments 1.5B
Accounts receivable 345.4M
Other receivables
Inventory 66.9M
Prepaid assets
Restricted cash
Assets held for sale
Hedging assets
Other current assets 99.7M
Non current assets 805.1M
Properties 308.7M
Land and improvements 7.7M
Machinery furniture equipment 46.2M
Construction in progress 6.5M
Leases 201.7M
Accumulated depreciation -230.4M
Goodwill
Investment properties
Financial assets
Intangible assets
Investments and advances
Other non current assets 213.7M
Total liabilities 3.6B
Current liabilities 1.0B
Accounts payable 75.4M
Accrued expenses 573.6M
Short term debt 35.7M
Deferred revenue 47.3M
Tax payable
Pensions 182.7M
Other current liabilities 96.3M
Non current liabilities 2.5B
Long term provisions
Long term debt 1.1B
Provision for risks and charges
Deferred liabilities
Derivative product liabilities
Other non current liabilities 1.5B
Shareholders equity
Common stock 1.1M
Retained earnings -6.2B
Other shareholders equity -29.4M
Total shareholders equity 57.2M
Additional paid in capital 6.3B
Treasury stock
Minority interest
Access /balance_sheet data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 5 minutes

11:24
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).